Medium materiality6/10
Iovance Biotherapeutics price target raised to $6 from $4 at Baird
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Baird raises IOVA's target to $6; current price is $6.21.
- Target $6; price $6.21; bullish setup.
Key facts
- 01
Target: $6
- 02
Posted price: $6.21
- 03
Analyst firm: Robert W. Baird
- 04
Analyst: Collen Kusy
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.